Freya Spielberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Freya Spielberg has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Alicia Marie Allen
National Center for Opioid and Addiction Research, Arkansas Children's Research Institute, 13 Children's Way, Slot 842, Little Rock, AR 72202, United States
1 shared publication - Allison J. Huff
College of Medicine, University of Arizona, USA
1 shared publication - Benjamin R. Brady
Comprehensive Center for Pain and Addiction at the University of Arizona Health Sciences. Tucson, AZ, USA
1 shared publication - Beth E. Meyerson
Harm Reduction Research Lab, College of Nursing, University of Arizona, Tucson, USA
1 shared publication - De’ Sha S. Wolf
Regional Research Institute, School of Social Work, Portland State University, Portland, OR, USA
1 shared publication - Greg T. Chism
Comprehensive Center for Pain and Addiction at the University of Arizona Health Sciences. Tucson, AZ, USA
1 shared publication
Latest Publications
- Open Access
- 10 July 2026
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 11 (4) , e1463
Impact of chronic pain on the families of U.S. adults
Introduction: Chronic pain (CP) can profoundly strain family systems, yet few population studies have explored prevalence and population dynamics of CP with high impact on families. Objectives: Examining prevalence and phenomenological characteristics of chronic pain with high impact on the families of U.S. adults. Situating HICP-family within a tiered cascade of functional impact. Methods: Prevalence estimated using 2023 National Health Interview Survey Data (n = 29,522) Results: Findings are as follows: (1) the population prevalence of CP with high impact on families (high-impact chronic pain [HICP]-Family) is 4.4% among U.S. adults, 18.1% among U.S. adults with CP, and 46.3% among U.S. adults with HICP; (2) HICP-Family is almost exclusively reported by those who have HICP that limits their individual functioning in life and work, yet most of those with HICP do not report concomitant HICP-Family; (3) among U.S. adults reporting both HICP and HICP-Family, the prevalence of clinically significant anxiety/depression symptoms is 46.1%; (4) among all U.S. adults with clinically significant anxiety/depression symptoms, the prevalence of HICP and concomitant HICP-Family is 14.9%. Conclusion: The need to develop effective supports and promote adaptive resilience in families highly affected by CP is clear. Clinical tools to support person-centered assessment of family and relational functioning, development of effective family-level interventions for U.S. adults, and collaborative models of care are needed.
- 10 July 2026
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 11 (4) , e1463
Open AccessImpact of chronic pain on the families of U.S. adults
Introduction: Chronic pain (CP) can profoundly strain family systems, yet few population studies have explored prevalence and population dynamics of CP with high impact on families. Objectives: Examining prevalence and phenomenological characteristics of chronic pain with high impact on the families of U.S. adults. Situating HICP-family within a tiered cascade of functional impact. Methods: Prevalence estimated using 2023 National Health Interview Survey Data (n = 29,522) Results: Findings are as follows: (1) the population prevalence of CP with high impact on families (high-impact chronic pain [HICP]-Family) is 4.4% among U.S. adults, 18.1% among U.S. adults with CP, and 46.3% among U.S. adults with HICP; (2) HICP-Family is almost exclusively reported by those who have HICP that limits their individual functioning in life and work, yet most of those with HICP do not report concomitant HICP-Family; (3) among U.S. adults reporting both HICP and HICP-Family, the prevalence of clinically significant anxiety/depression symptoms is 46.1%; (4) among all U.S. adults with clinically significant anxiety/depression symptoms, the prevalence of HICP and concomitant HICP-Family is 14.9%. Conclusion: The need to develop effective supports and promote adaptive resilience in families highly affected by CP is clear. Clinical tools to support person-centered assessment of family and relational functioning, development of effective family-level interventions for U.S. adults, and collaborative models of care are needed.